(Q38295283)

1 September 2017

title

Roscovitine inhibits ERK1/2 activation induced by angiotensin II in vascular smooth muscle cells (English)

1 reference

1 September 2017

Ai-Ying Li

1

1 reference

1 September 2017

Mei Han

series ordinal

2

1 reference

1 September 2017

Bin Zheng

series ordinal

3

1 reference

1 September 2017

Jin-Kun Wen

series ordinal

4

1 reference

1 September 2017

language of work or name

English

0 references

publication date

18 December 2007

1 reference

1 September 2017

1 reference

1 September 2017

volume

582

1 reference

1 September 2017

issue

2

1 reference

1 September 2017

page(s)

243-248

1 reference

The Cyclin-dependent kinase inhibitor CYC202 (R-roscovitine) inhibits retinoblastoma protein phosphorylation, causes loss of Cyclin D1, and activates the mitogen-activated protein kinase pathway

1 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

Roscovitine: a novel regulator of P/Q-type calcium channels and transmitter release in central neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

Serum deprivation results in redifferentiation of human umbilical vascular smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

Role of Ras/PKCzeta/MEK/ERK1/2 signaling pathway in angiotensin II-induced vascular smooth muscle cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

Signal transduction of angiotensin II type 1 receptor through receptor tyrosine kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

H(2)O(2)-induced egr-1, fra-1, and c-jun gene expression is mediated by tyrosine kinase in aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

Differential cyclin E expression in human in-stent stenosis smooth muscle cells identifies targets for selective anti-restenosis therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

Antioxidants inhibit JNK and p38 MAPK activation but not ERK 1/2 activation by angiotensin II in rat aortic smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2007.12.011

10.1016/J.FEBSLET.2007.12.011

21 January 2018

Identifiers

DOI

1 reference

1 September 2017

1 reference